$0.693
-0.072 (-10.36%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Milestone Pharmaceuticals Inc (MIST) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting MIST is Strong sell.
Milestone Pharmaceuticals Inc (MIST) 20-Day simple moving average is 0.73, while Milestone Pharmaceuticals Inc (MIST) share price is $—, making it Sell.
Milestone Pharmaceuticals Inc (MIST) 60-Day simple moving average is 0.90, while Milestone Pharmaceuticals Inc (MIST) share price is $—, making it Sell.
Technical Analysis for MIST
AI Technical MISTAs of 2026-11-03, the technical board for Milestone Pharmaceuticals Inc (MIST) reads strong sell: 0 indicators are flashing buy, 9 are indicating sell, and 4 are neutral. Price at $0.69 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 41.638, MACD stands at -0.0313 (Sell), Stochastic %K stands at 53.859, Stochastic %D stands at 55.269 and CCI stands at -36.672.
MIST trades below the 60-day SMA (0.90) and below the 200-day SMA (1.35). Immediate resistance sits at Classic R1 0.83, then R2 0.93. Support sits at Classic S1 0.62, then S2 0.52.
Milestone Pharmaceuticals Inc (MIST) Support & Resistance Level
Milestone Pharmaceuticals Inc (MIST) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 41.638 |
| STOCHk_14_3_3 | 53.859 |
| STOCHd_14_3_3 | 55.269 |
| CCI_20 | -36.672 |
| AO_5_34 | -0.020 |
| MOM_10 | -0.010 |
| MACD_12_26_9 | -0.031 |
Milestone Pharmaceuticals Inc (MIST) Relative Strength Index (RSI_14) is 41.638, creating a Neutral signal.
Milestone Pharmaceuticals Inc (MIST) Stochastic %K is 53.859, creating a Neutral signal.
Milestone Pharmaceuticals Inc (MIST) Stochastic %D is 55.269, creating a Neutral signal.
Milestone Pharmaceuticals Inc (MIST) CCI_20 is -36.672, creating a Neutral signal.
Milestone Pharmaceuticals Inc (MIST) Awesome Oscillator (AO) is -0.020, creating a Sell signal.
Milestone Pharmaceuticals Inc (MIST) Momentum (MOM) is -0.010, creating a Sell signal.
Milestone Pharmaceuticals Inc (MIST) Moving Average Convergence Divergence (MACD) is -0.031, creating a Sell signal.
Milestone Pharmaceuticals Inc (MIST) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.736 | Sell |
| MA_10 | 0.721 | Sell |
| MA_20 | 0.733 | Sell |
| MA_60 | 0.900 | Sell |
| MA_200 | 1.348 | Sell |
| MA_250 | 1.524 | Sell |
Milestone Pharmaceuticals Inc (MIST) 5-Day simple moving average is 0.736, while Milestone Pharmaceuticals Inc (MIST) share price is $, making it a Sell.
Milestone Pharmaceuticals Inc (MIST) 10-Day simple moving average is 0.721, while Milestone Pharmaceuticals Inc (MIST) share price is $, making it a Sell.
Milestone Pharmaceuticals Inc (MIST) 20-Day simple moving average is 0.733, while Milestone Pharmaceuticals Inc (MIST) share price is $, making it a Sell.
Milestone Pharmaceuticals Inc (MIST) 60-Day simple moving average is 0.900, while Milestone Pharmaceuticals Inc (MIST) share price is $, making it a Sell.
Milestone Pharmaceuticals Inc (MIST) 200-Day simple moving average is 1.348, while Milestone Pharmaceuticals Inc (MIST) share price is $, making it a Sell.
Milestone Pharmaceuticals Inc (MIST) 250-Day simple moving average is 1.524, while Milestone Pharmaceuticals Inc (MIST) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.